Paula Camps-Massa
Biographic Data
| ID | 9019858 |
|---|---|
| NAME | Paula Camps-Massa |
| GIVEN NAMES | Paula |
| FAMILY NAME | Camps-Massa |
| SIGNATURE | CAMPS-MASSA P |
| AFFILIATIONS | Instituto de Salud Carlos III |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Gut microbiome shift in long Covid: Impact of disease and montelukast treatment
Background: Long COVID-19 is a post-infectious syndrome with persistent symptoms that can involve multiple organ systems. Evidence suggests that SARS-CoV-2 infection may disrupt gut microbiome composition, potentially contributing to long-term effects. As treatment remains symptom-based, interest has grown in repurposing drugs like montelukast. However, non-antibiotic medications may also alter gut microbial communities, raising questions about t…
No prominent works on this page.
Gut microbiome shift in long Covid: Impact of disease and montelukast treatment
Background: Long COVID-19 is a post-infectious syndrome with persistent symptoms that can involve multiple organ systems. Evidence suggests that SARS-CoV-2 infection may disrupt gut microbiome composition, potentially contributing to long-term effects. As treatment remains symptom-based, interest has grown in repurposing drugs like montelukast. However, non-antibiotic medications may also alter gut microbial communities, raising questions about t…
Coronavirus (1 works) · Disease (1 works) · Gut flora (1 works) · Gut microbiome (1 works) · Gut microbiota and health (1 works) · Immune responses and vaccinations (1 works) · Long-Term Effects of COVID-19 (1 works) · Microbiome (1 works) · Respiratory system (1 works) · Respiratory tract (1 works)